Navigation Links
La Jolla Institute joins Sanford Consortium for Regenerative Medicine

SAN DIEGO (Oct.27, 2011) The La Jolla Institute for Allergy & Immunology has become the fifth organization in the prestigious Sanford Consortium for Regenerative Medicine, joining colleagues from the Salk Institute for Biological Studies, The Scripps Research Institute, University of California, San Diego and the Sanford-Burnham Medical Research Institute in the first-of-its-kind multi-institutional stem cell research collaboration.

Slated to open its new collaborative research facility in November, the Sanford Consortium will marshal the intellectual resources of its five collaborating organizations all world-leaders in life sciences to improve human health through stem cell research.

"We are pleased that the La Jolla Institute has accepted our invitation to join the Sanford Consortium," said Edward W. Holmes, M.D., the Consortium's president and chief executive officer, adding that the La Jolla Institute's strong immunology expertise will complement and expand that of the collaborating organizations. "The foundation of the Sanford Consortium is to establish a "collaboratory" that brings together investigators with different expertise to exploit stem cells to improve human health," he said. "The addition of a body of investigators with expertise in immunology will expand the Consortium's breadth of science in a number of important ways."

A biomedical research nonprofit, the La Jolla Institute focuses on fighting disease through the study of the immune system and was recently ranked among the top five organizations worldwide for research impact in immunology.

Mitchell Kronenberg, Ph.D., La Jolla Institute president and chief scientific officer, said the Consortium offers strong potential for transformative research. "The Collaboratory will foster the kind of cross-disciplinary, cross-institutional research that accelerates discovery and leads to breakthroughs," he said. "We're all very excited about the possibilities."

In becoming part of the Consortium, La Jolla Institute faculty member Anjana Rao, Ph.D., a prominent genetics and cell biology researcher, will move part of her lab into the new building. Dr. Kronenberg becomes a member of the Consortium's 10-member Board of Directors, which includes UC San Diego Chancellor Marye Anne Fox, Ph.D., and leaders from the other collaborating organizations. The Board is co-chaired by San Diego philanthropists Irwin M. Jacobs, Sc.D., Malin Burnham and John Moores, and South Dakota-based philanthropist T. Denny Sanford, who provided a $30 million naming gift to the Consortium.

While retaining their independent research affiliations, researchers from the five organizations will work side by side to hasten the pace of stem cell research progress, and to discover and develop diagnostics, therapies and cures to relieve human suffering from chronic disease and injury.

Louis R. Coffman, Sanford Consortium vice president & chief operating officer, praised the La Jolla Institute's addition to the collaboration. "Their researchers have a wonderful reputation for science and perfectly align with the Consortium's overriding goal to catalyze great science."

Lawrence Goldstein, Ph.D., director of UC San Diego's Stem Cell Program, who will locate his lab in the Collaboratory, offered similar sentiments. "Obviously, we're delighted to have the involvement of such an outstanding Institute," he said. "This will not only bring the unique expertise of Anjana Rao to the Consortium, but we anticipate that it will boost collaborations between the Consortium organizations and many of the fine immunologists from the La Jolla Institute."

Coffman added that "Anjana is a wonderful addition to the San Diego research community and the other Consortium scientists are enthused about collaborating with her."

Dr. Rao joined the La Jolla Institute in 2010 as head of the Institute's Division of Signaling and Gene Expression, after many years as a faculty member at Harvard Medical School and the Immune Disease Institute in Boston. A member of the National Academy of Sciences, one of the highest honors in American Science, Dr. Rao is well known for her many breakthrough discoveries that span a wide range of biomedical research, among them a calcium channel that regulates a family of transcription factors used by white blood cells to fight disease, and a family of DNA-modifying enzymes that have important roles in stem cell function and in cancer.

"The Consortium will be an ideal place to connect with people working on stem cell biology and neurobiology, which is where some of my research is tending lately," she said. "I look forward to the rare opportunity, which the Sanford Consortium affords, to interact with some of the world's top stem cell scientists on a daily basis. I expect the synergy to produce some remarkable science."

The Consortium, a nonprofit organization, was originally assembled in 2006 as the San Diego Consortium for Regenerative Medicine with four members (Scripps, Salk, Sanford-Burnham and UC San Diego), but renamed in September 2008 after T. Denny Sanford's naming donation.


Contact: Bonnie Ward
La Jolla Institute for Allergy and Immunology

Related biology news :

1. La Jolla Institute discovers novel mechanism for preventing infection via bodys mucosal borders
2. La Jolla Institute discovers previously unknown cell interaction key in immune system attacks
3. La Jolla Institute opens major RNAi center for identifying genetic triggers of disease
4. La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders
5. La Jolla Institute-led team illuminates cell pathway key to insulin resistance in Type 2 diabetes
6. La Jolla Institute validates Type 1 diabetes computer models predictive success through lab testing
7. La Jolla Institute scientist Klaus Ley receives Malpighi award
8. La Jolla Institute scientist leads team which discovers important new player in diabetes onset
9. Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award
10. La Jolla Institute discovers novel tumor suppressor
11. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
Post Your Comments:
(Date:8/23/2017)... 2017  The general public,s help is being enlisted in what,s thought ... in and on the human body –and are believed to affect health.  ... The Microbiome Immunity Project is the ... with the gut. The project's goal is to help advance scientific knowledge ... ...
(Date:6/23/2017)... N.Y. and ITHACA, N.Y. ... ) and Cornell University, a leader in dairy research, ... with bioinformatics designed to help reduce the chances that ... With the onset of this dairy project, Cornell University ... Consortium for Sequencing the Food Supply Chain, a food ...
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences , ... life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer ... “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology: